Marie Brännström

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Joe Bentz, Michael O′Connor, Dallas Bednarczyk et al. · Drug Metabolism and Disposition · 2013 · 150 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +9

Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition

Damiano La Zara, Feilong Sun, Fuweng Zhang et al. · ACS Nano · 2021 · 49 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals

Tove Berg, Tove Hegelund-Myrbäck, Johan Öckinger et al. · Respiratory Research · 2018 · 41 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2

Stefan von Berg, Yafeng Xue, Mia Collins et al. · ACS Medicinal Chemistry Letters · 2019 · 18 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Combined in Vitro–in Vivo Approach To Assess the Hepatobiliary Disposition of a Novel Oral Thrombin Inhibitor

Elin M. Matsson, Ulf G. Eriksson, Johan Palm et al. · Molecular Pharmaceutics · 2013 · 15 citations

Pharmacy, Pharmacokinetics, Pharmacology +17